Sort
10,766 grants matching “checkpoint inhibitor”
Project 1 Targeting the PI3K Pathway to Overcome Resistance to Immunotherapy in Melanomas with Loss of PTEN
$531,105Michael Davies · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
Systems analysis of cell-cell communication networks and immune activity in the melanoma tumor microenvironment
$530,976Kathryn Miller-Jensen · Yale University · U01 · FY2024 · CA
Integrated Discovery Pipeline for Tumor Neoantigens
$530,736Beatriz M. Carreno · University Of Pennsylvania · R01 · FY2019 · CA
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial
$530,360Elizabeth Marion Jaffee · Johns Hopkins University · R01 · FY2024 · CA
Translation of commensal bacteria mechanism for immunotherapy
$530,298Howard C Hang · Rockefeller University · R01 · FY2020 · CA
Studies of Materials with Physiological Properties
$530,266Harvard University · R01 · FY2003 · GM
Dissecting the immunomodulatory effects of NK cells on immune responses to cancer
$530,015Kevin C Barry · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
Project 1-Combination Immunotherapy with Radioligned Therapy for Metastatic Prostate Cancer
$529,989Lawrence Fong · University Of California, San Francisco · P50 · FY2025 · CA
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
$529,878Nikhil Joshi · Yale University · R01 · FY2024 · CA
Cell-Selective CpG-STAT3 Inhibitors for Radioimmunotherapy of Malignant Glioma
$529,603Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2018 · CA
STING-Activating Polymeric Nanovaccines for T Cell Therapy of Melanoma
$529,462Jinming Gao · Ut Southwestern Medical Center · U01 · FY2020 · CA
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy
$529,313Andre Elias Nel · University Of California Los Angeles · R01 · FY2022 · CA
Fractionated photoimmunotherapy to harness low-dose immunostimulation in ovarian cancer
$529,280Bryan Quilty Spring · Northeastern University · U01 · FY2023 · CA
Dual-specificity phosphatase action in muscle disease
$529,254Anton M Bennett · Yale University · R01 · FY2023 · AR
Nanovaccine platforms to combat pancreatic cancer
$529,150Balaji Narasimhan · Iowa State University · U01 · FY2019 · CA
Immunogenomic predictors of outcomes in patients with locally advanced cervical cancer treated with immunotherapy and chemoradiation
$529,039Dmitriy Zamarin · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Interrogating Type I Interferon signaling in breast cancer brain metastasis
$529,002Qing Chen · Wistar Institute · R01 · FY2024 · CA
Defining the Pathogenesis and Prognosis of Human Acute Interstitial Nephritis
$528,788Lloyd G Cantley · Yale University · R01 · FY2022 · DK
Glutaredoxin, Glutathione Metabolism and Lung Cancer
$528,642Yvonne M.w. Janssen-Heininger · University Of Vermont & St Agric College · R01 · FY2025 · CA
Defining the Pathogenesis and Prognosis of Human Acute Interstitial Nephritis
$528,629Lloyd G Cantley · Yale University · R01 · FY2021 · DK
Targeting PD-L1 interactome signaling to enhance immunotherapy efficacy in head and neck squamous cell cancer
$528,427Antonio Jimeno · University Of Colorado Denver · R01 · FY2025 · CA
Plasmonic nanoparticle-mediated immunotherapy to treat metastatic cancer
$528,416Tuan Vo-Dinh · Duke University · R01 · FY2022 · EB
CPTR - Mass Spectrometry Unit
$528,384Lisa Jenkins · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA
TCR-antigen foundation model to empower TCR-based diagnostics and therapeutics
$528,157Tao Wang · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · AI
Targeting PIM-2 Kinase for Improving Cancer Immunotherapy
$528,033Xue-Zhong Yu · Medical College Of Wisconsin · R01 · FY2023 · CA